White adipose tissue-derived factors and prostate cancer progression: mechanisms and targets for interventions

Hales, C. M., Carroll, M. D., Fryar, C. D., & Ogden, C. L. (2020). Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief, (360), 1–8.

Nomura, A. M. (2001). Body size and prostate cancer. Epidemiologic Reviews, 23(1), 126–131.

CAS  Article  Google Scholar 

Porter, M. P., & Stanford, J. L. (2005). Obesity and the risk of prostate cancer. Prostate, 62(4), 316–321.

Article  Google Scholar 

Roehl, K. A., Han, M., Ramos, C. G., Antenor, J. A., & Catalona, W. J. (2004). Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results. Journal of Urology, 172(3), 910–914. https://doi.org/10.1097/01.ju.0000134888.22332.bb

Article  PubMed  Google Scholar 

Pound, C. R., Partin, A. W., Eisenberger, M. A., Chan, D. W., Pearson, J. D., & Walsh, P. C. (1999). Natural history of progression after PSA elevation following radical prostatectomy. JAMA, 281(17), 1591–1597.

CAS  Article  Google Scholar 

Flavin, R., Zadra, G., & Loda, M. (2011). Metabolic alterations and targeted therapies in prostate cancer. The Journal of Pathology, 223(2), 283–294. https://doi.org/10.1002/path.2809

CAS  Article  PubMed  Google Scholar 

Cao, Y., & Ma, J. (2011). Body mass index, prostate cancer–specific mortality, and biochemical recurrence: A systematic review and meta-analysis. Cancer Prevention Research, 4(4), 486–501. https://doi.org/10.1158/1940-6207.capr-10-0229

CAS  Article  PubMed  Google Scholar 

Freedland, S. J., Terris, M. K., Presti, J. C., Jr., Amling, C. L., Kane, C. J., Trock, B., et al. (2004). Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. Journal of Urology, 172(2), 520–524. https://doi.org/10.1097/01.ju.0000135302.58378.ae

Article  PubMed  Google Scholar 

Campeggi, A., Xylinas, E., Ploussard, G., Ouzaid, I., Fabre, A., Allory, Y., et al. (2012). Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy. Urology, 80(3), 576–584. https://doi.org/10.1016/j.urology.2012.04.066

Article  PubMed  Google Scholar 

Haque, R., Van Den Eeden, S. K., Wallner, L. P., Richert-Boe, K., Kallakury, B., Wang, R., et al. (2014). Association of body mass index and prostate cancer mortality. Obesity Research & Clinical Practice, 8(4), e374-381. https://doi.org/10.1016/j.orcp.2013.06.002

Article  Google Scholar 

Joshu, C. E., Mondul, A. M., Menke, A., Meinhold, C., Han, M., Humphreys, E. B., et al. (2011). Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. Cancer Prevention Research (Philadelphia, Pa.), 4(4), 544–551. https://doi.org/10.1158/1940-6207.capr-10-0257

Article  Google Scholar 

Whitley, B. M., Moreira, D. M., Thomas, J. A., Aronson, W. J., Terris, M. K., Presti, J. C., Jr., et al. (2011). Preoperative weight change and risk of adverse outcome following radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database. Prostate Cancer and Prostatic Diseases, 14(4), 361–366. https://doi.org/10.1038/pcan.2011.42

CAS  Article  PubMed  Google Scholar 

Chen, Q., Chen, T., Shi, W., Zhang, T., Zhang, W., Jin, Z., et al. (2016). Adult weight gain and risk of prostate cancer: A dose-response meta-analysis of observational studies. International Journal of Cancer, 138(4), 866–874. https://doi.org/10.1002/ijc.29846

CAS  Article  PubMed  Google Scholar 

Bonn, S. E., Wiklund, F., Sjolander, A., Szulkin, R., Stattin, P., Holmberg, E., et al. (2014). Body mass index and weight change in men with prostate cancer: Progression and mortality. Cancer Causes and Control, 25(8), 933–943. https://doi.org/10.1007/s10552-014-0393-3

Article  PubMed  Google Scholar 

Troeschel, A. N., Hartman, T. J., Jacobs, E. J., Stevens, V. L., Gansler, T., Flanders, W. D., et al. (2020). Postdiagnosis body mass index, weight change, and mortality from prostate cancer, cardiovascular disease, and all causes among survivors of nonmetastatic prostate cancer. Journal of Clinical Oncology, 38(18), 2018–2027. https://doi.org/10.1200/JCO.19.02185

Article  PubMed  PubMed Central  Google Scholar 

Allott, E. H., Masko, E. M., & Freedland, S. J. (2013). Obesity and prostate cancer: Weighing the evidence. European Urology, 63(5), 800–809. https://doi.org/10.1016/j.eururo.2012.11.013

CAS  Article  PubMed  Google Scholar 

Spitz, M. R., Strom, S. S., Yamamura, Y., Troncoso, P., Babaian, R. J., Scardino, P. T., et al. (2000). Epidemiologic determinants of clinically relevant prostate cancer. International Journal of Cancer, 89(3), 259–264.

CAS  Article  Google Scholar 

Eheman, C., Henley, S. J., Ballard-Barbash, R., Jacobs, E. J., Schymura, M. J., Noone, A. M., et al. (2012). Annual Report to the Nation on the status of cancer, 1975–2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer, 118(9), 2338–2366. https://doi.org/10.1002/cncr.27514

Article  PubMed  Google Scholar 

Zadra, G., Photopoulos, C., & Loda, M. (2013). The fat side of prostate cancer. Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids, 1831(10), 1518–1532. https://doi.org/10.1016/J.Bbalip.2013.03.010

Blando, J., Saha, A., Kiguchi, K., & DiGiovanni, J. (2013). Obesity, inflammation and prostate cancer. In A. J. Dannenberg, & N. A. Berger (Eds.), Obesity, inflammation and cancer (Vol. 7, pp. 235–256, Energy Balance and Cancer, Vol. 7). Springer.

De Nunzio, C., Albisinni, S., Freedland, S. J., Miano, L., Cindolo, L., Finazzi Agro, E., et al. (2013). Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: A prospective multicenter Italian cohort study. Urologic Oncology, 31(7), 997–1002. https://doi.org/10.1016/j.urolonc.2011.08.007

Article  PubMed  Google Scholar 

van Kruijsdijk, R. C., van der Wall, E., & Visseren, F. L. (2009). Obesity and cancer: The role of dysfunctional adipose tissue. Cancer Epidemiology, Biomarkers & Prevention, 18(10), 2569–2578. https://doi.org/10.1158/1055-9965.EPI-09-0372

CAS  Article  Google Scholar 

Lysaght, J., van der Stok, E. P., Allott, E. H., Casey, R., Donohoe, C. L., Howard, J. M., et al. (2011). Pro-inflammatory and tumour proliferative properties of excess visceral adipose tissue. Cancer Letters, 312(1), 62–72. https://doi.org/10.1016/j.canlet.2011.07.034

CAS  Article  PubMed  Google Scholar 

Coussens, L. M., & Werb, Z. (2002). Inflammation and cancer. Nature, 420(6917), 860–867. https://doi.org/10.1038/nature01322

CAS  Article  PubMed  PubMed Central  Google Scholar 

Cowey, S., & Hardy, R. W. (2006). The metabolic syndrome: A high-risk state for cancer? American Journal of Pathology, 169(5), 1505–1522. https://doi.org/10.2353/ajpath.2006.051090

CAS  Article  PubMed  PubMed Central  Google Scholar 

Park, J., Euhus, D. M., & Scherer, P. E. (2011). Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocrine Reviews, 32(4), 550–570. https://doi.org/10.1210/er.2010-0030

CAS  Article  PubMed  PubMed Central  Google Scholar 

Baillargeon, J., & Rose, D. P. (2006). Obesity, adipokines, and prostate cancer (review). International Journal of Oncology, 28(3), 737–745.

CAS  PubMed  Google Scholar 

Trayhurn, P., & Wood, I. S. (2004). Adipokines: Inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition, 92(3), 347–355.

CAS  Article  Google Scholar 

Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011). Adipokines in inflammation and metabolic disease. Nature Reviews Immunology, 11(2), 85–97. https://doi.org/10.1038/nri2921

CAS  Article  PubMed  PubMed Central  Google Scholar 

Khandekar, M. J., Cohen, P., & Spiegelman, B. M. (2011). Molecular mechanisms of cancer development in obesity. Nature Reviews Cancer, 11(12), 886–895. https://doi.org/10.1038/nrc3174

CAS  Article  PubMed  Google Scholar 

Roberts, D. L., Dive, C., & Renehan, A. G. (2010). Biological mechanisms linking obesity and cancer risk: New perspectives. Annual Review of Medicine, 61, 301–316. https://doi.org/10.1146/annurev.med.080708.082713

CAS  Article  PubMed  Google Scholar 

Grossmann, M. E., Ray, A., Nkhata, K. J., Malakhov, D. A., Rogozina, O. P., Dogan, S., et al. (2010). Obesity and breast cancer: Status of leptin and adiponectin in pathological processes. Cancer and Metastasis Reviews, 29(4), 641–653. https://doi.org/10.1007/s10555-010-9252-1

CAS  Article  PubMed  Google Scholar 

Johnson, A. R., Milner, J. J., & Makowski, L. (2012). The inflammation highway: Metabolism accelerates inflammatory traffic in obesity. Immunological Reviews, 249(1), 218–238. https://doi.org/10.1111/j.1600-065X.2012.01151.x

CAS  Article  PubMed  PubMed Central  Google Scholar 

Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W., Jr. (2003). Obesity is associated with macrophage accumulation in adipose tissue. The Journal of Clinical Investigation, 112(12), 1796–1808. https://doi.org/10.1172/JCI19246

CAS  Article  PubMed  PubMed Central  Google Scholar 

Lengyel, E., Makowski, L., DiGiovanni, J., & Kolonin, M. G. (2018). Cancer as a matter of fat: The crosstalk between adipose tissue and tumors. Trends in Cancer, 4(5), 374–384. https://doi.org/10.1016/j.trecan.2018.03.004

CAS  Article  PubMed  PubMed Central  Google Scholar 

Laurent, V., Guerard, A., Mazerolles, C., Le Gonidec, S., Toulet, A., Nieto, L., et al. (2016). Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity. [Research Support, Non-U.S. Gov’t]. Nature Communications, 7, 10230. https://doi.org/10.1038/ncomms10230

Palm, W., & Thompson, C. B. (2017). Nutrient acquisition strategies of mammalian cells. Nature, 546(7657), 234–242. https://doi.org/10.1038/nature22379

CAS  Article  PubMed  PubMed Central  Google Scholar 

Ye, H., Adane, B., Khan, N., Sullivan, T., Minhajuddin, M., Gasparetto, M., et al. (2016). Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche. Cell Stem Cell, 19(1), 23–37. https://doi.org/10.1016/j.stem.2016.06.001

CAS  Article  PubMed  PubMed Central  Google Scholar 

Ribeiro, R., Monteiro, C., Silvestre, R., Castela, A., Coutinho, H., Fraga, A., et al. (2012). Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma. [Research Support, Non-U.S. Gov’t]. Experimental Biology and Medicine, 237(10), 1155–1162. https://doi.org/10.1258/ebm.2012.012131

van Roermund, J. G., Hinnen, K. A., Tolman, C. J., Bol, G. H., Witjes, J. A., Bosch, J. L., et al. (2011). Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients. BJU International, 107(11), 1775–1779. https://doi.org/10.1111/j.1464-410X.2010.09811.x

Article  PubMed 

留言 (0)

沒有登入
gif